OR WAIT null SECS
February 15, 2020
Technology and capacity investments create opportunities in the cell and gene therapy arena for CDMOs and biopharma alike.
February 01, 2020
CDMOs and CMOs will continue to invest in biopharmaceutical services and facilities as the bio/pharmaceutical industry looks to biosimilars and personalized medicine.
January 08, 2020
Catalent completes purchase of biologics fill-finish and oral solid dose facility in Anagni, Italy
November 22, 2019
New training facilities, laboratories, packaging, gene therapy manufacturing, and biologics manufacturing highlight Thermo Fisher Scientific expansions.
July 17, 2019
Catalent recently held a groundbreaking ceremony at its Bloomington, Indiana pharmaceutical fill/finish site.
June 19, 2019
Lyophilization Services of New England acquired a sterile injectables manufacturing facility in León, Spain.
January 03, 2019
The Massachusetts site, formerly associated with an affiliate of Shire, is Rentschler Biopharma’s first facility in the US.
October 01, 2018
The maturation of single-use technologies presents commercial bioprocessing options for small-volume drug products.
August 14, 2018
Pharmaceutical scientist association announces upcoming term’s board of directors.
Drug product approval from FDA follows previous approvals from European and Japanese authorities.